The purpose of this study was to investigate HER2 status in CB-MEs from gastric cancer patients and to assess the HER2 status concordance rate between primary gastric adenocarcinomas and corresponding CB-MEs. This evidence concerns the gene ERBB2 and gastric adenocarcinoma.